Full Press Release Details
WALTHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences:
Morgan Stanley 2023 Healthcare Conference: Fireside chat on Monday, September 11, 2023, at 10:00 a.m. ET
Baird's 2023 Global Healthcare Conference: Presentation on Tuesday, September 12, 2023, at 12:15 p.m. ET
H.C. Wainwright Healthcare Conference: Fireside chat on Tuesday, September 12, 2023, at 3:00 p.m. ET
When available, the live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcasts will be available for approximately 90 days following the event.